Glen Eagle Advisors, LLC

SEC CIK: 0002029317
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

ARQT holding history

Arcutis Biotherapeutics, Inc. in every 13F filed by Glen Eagle Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ARQT overview All 13F holders of ARQT Full Q2 2026 holdings

Shares (Q4 2021): 0; Sold out in Q4 2021
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q2 2021

Holdings of ARQT by Glen Eagle Advisors, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q4 2021	0	$0	0.0%	−400−100.0%	Sold out	Holders
Q3 2021	400	$9.56K	<0.1%	+160+66.7%	Added	Holders
Q2 2021	240	$6.55K	<0.1%	+240	New	Holders